Merck KGaA is a leading global science and technology company headquartered in Darmstadt, Germany. Known for its diverse portfolio, Merck operates across three major sectors: Healthcare, Life Science,... Merck KGaA is a leading global science and technology company headquartered in Darmstadt, Germany. Known for its diverse portfolio, Merck operates across three major sectors: Healthcare, Life Science, and Performance Materials. In the Healthcare sector, Merck develops prescription medicines, over-the-counter products, and biopharmaceuticals aimed at treating various medical needs. The Life Science division provides innovative tools and laboratory supplies essential for scientific research, biopharmaceutical manufacturing, and quality control. Additionally, the Performance Materials segment focuses on high-tech solutions, offering specialty chemicals for applications in electronics, automotive coatings, and cosmetics.
Merck KGaA plays a vital role in advancing healthcare and technology on a global scale, driven by a commitment to scientific innovation and sustainable practices. The company's substantial contributions to pharmaceuticals and life sciences bolster essential industry standards and research capabilities, impacting a wide array of sectors from industrial manufacturing to healthcare delivery. Their strategic emphasis on R&D positions Merck as a pivotal entity supporting both emerging research fields and established markets, fostering advancements that underscore its influence in the global financial market.
In 2024, Merck KGaA was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Merck KGaA has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Merck KGaA are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Turnover
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
3.5 CCM/CCA - Manufacture of energy efficiency equipment for buildings
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Opex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
3.5 CCM/CCA - Manufacture of energy efficiency equipment for buildings
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Capex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
3.5 CCM/CCA - Manufacture of energy efficiency equipment for buildings
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
4.1 CCM/CCA - Electricity generation using solar photovoltaic technology
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
7.2 CCM/CCA - Renovation of existing buildings
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Limited Data Preview
You are viewing a limited preview of Merck KGaA’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to 2022.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Merck KGaA’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Merck KGaA’s data sources below and access millions more through our Disclosure Search.
a. Merck KGaA's Annual Report 2024
b. Merck KGaA's Annual Report 2023
c. Merck KGaA's Annual Report 2022
Insights into Merck KGaA's Revenues from Sustainable Activities
In 2024, Merck KGaA reported EU Taxonomy-eligible revenues of EUR 6.24 billion, representing 29.48% of its total turnover. Of this amount, EUR 1.00 million of Merck KGaA's revenues was classified as EU Taxonomy-aligned, indicating that 0.01% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Merck KGaA's Taxonomy-Eligible Turnover Over Time
Total Taxonomy Aligned A1 Turnover
Total Taxonomy Eligible but Not Aligned A2 Turnover
Have Merck KGaA's revenues become more sustainable over time?
Since 2022, Merck KGaA's taxonomy-aligned revenues decreased by 66.67%, indicating a long-term decline in environmentally sustainable revenue performance.a, c
Compared to the previous year (2023), Merck KGaA's taxonomy-aligned revenues decreased by 66.67%, suggesting that Merck KGaA may have deprioritized sustainable activities, shifted focus away from green offerings, or reduced transparency in its EU Taxonomy reporting.a, b
How much of Merck KGaA's revenue is eligible under the EU Taxonomy?
In 2024, Merck KGaA reported that EUR 6.24 billion of its revenue was eligible under the EU Taxonomy, representing 29.48% of the company's total turnover. Of this amount, EUR 1.00 million (0.01% of total revenue) was classified as Taxonomy-aligned. This means that 29.48% of Merck KGaA's revenue is eligible but not aligned, indicating that these activities did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards.a
How much of Merck KGaA's eligible revenue is aligned with the EU Taxonomy?
In 2024, Merck KGaA reported that EUR 1.00 million of its revenue was aligned under the EU Taxonomy, representing 0.01% of its total turnover.a
This low alignment highlights either a limited focus on green activities or early-stage adoption of sustainability frameworks, underscoring opportunities for further alignment with EU climate objectives.
Merck KGaA's Eligibility & Alignment Overview
Merck KGaA's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Turnover
Total Taxonomy Eligible but Not Aligned A2 Turnover
How is Merck KGaA's taxonomy-aligned revenue distributed across the EU environmental objectives?
In 2024, Merck KGaA reported that its taxonomy-aligned revenue was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.01%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%
How much revenue does Merck KGaA earn from selling climate-related solutions ?
In 2024, Merck KGaA reported that EUR 2.12 million of its total revenue was associated with activities contributing to the EU taxonomy climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This accounted for 0.01% of the company's total revenue,indicating that Merck KGaAhas limited exposureon solutions that support climate action through its commercial activities.a
Insights into Merck KGaA's CAPEX from Sustainable Activities
In 2024, Merck KGaA reported EU Taxonomy-eligible CAPEX of EUR 112.00 million,representing 4.8% of its total CAPEX. Of this amount, EUR 2.00 million of Merck KGaA's CAPEX was classified as EU Taxonomy-aligned, indicating that 0.07% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Merck KGaA's Taxonomy-Eligible Capex Over Time
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
Have Merck KGaA's increased its investment in sustainable activities over time?
Since 2022, Merck KGaA's taxonomy-aligned capital expenditure (CAPEX)decreased by 87.93%,indicating a long-term decline in green capital deployment, potentially signaling shifting priorities or reduced focus on sustainability-linked investments.a, c
Compared to the previous year (2023), Merck KGaA's taxonomy-aligned CAPEX decreased by 89.39%,suggesting that Merck KGaA may have scaled back investments in sustainable projects, reprioritized its capital deployment, or reduced transparency in its taxonomy-aligned disclosures.a, b
How much of Merck KGaA's capital expenditure (CAPEX) is eligible under the EU Taxonomy?
In 2024, Merck KGaA reported that EUR 112.00 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 4.8% of the company's total CAPEX. Of this amount, EUR 2.00 million (0.07% of total CAPEX) was classified as Taxonomy-aligned. This means that 4.73% of Merck KGaA's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Merck KGaA's eligible CAPEX is aligned with the EU Taxonomy?
In 2024, Merck KGaA reported that EUR 2.00 million of its CAPEX was aligned under the EU Taxonomy, representing 0.07% of its total capital investment.a
This low alignment reflects that Merck KGaA is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.
Merck KGaA's Eligibility & Alignment Overview
Merck KGaA's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
How is Merck KGaA's taxonomy-aligned CAPEX distributed across the EU environmental objectives?
In 2024, Merck KGaA reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.07%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%
How much Merck KGaA is investing in climate-related solutions?
In 2024, Merck KGaA allocated EUR 1.64 million of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.07% of the company's total capital expenditure,indicating that Merck KGaAhas only marginally directed its capital expenditure toward climate-related activities, suggesting limited alignment with climate objectives.a
Insights into Merck KGaA's OPEX from Sustainable Activities
In 2024, Merck KGaA reported EU Taxonomy-eligible OPEX of EUR 35.00 million,representing 1.35% of its total operating expenses (OPEX). Of this amount, EUR 1.00 million of Merck KGaA's OPEX was classified as EU Taxonomy-aligned, indicating that 0.02% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Merck KGaA's Taxonomy-Eligible Opex Over Time
Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex
Have Merck KGaA's increased its spending in sustainable activities over time?
Compared to the previous year (2023), Merck KGaA's taxonomy-aligned OPEX remained relatively stable, indicating that Merck KGaA maintained consistent levels of sustainable operational expenditure, without significant changes in taxonomy-aligned activity coverage.a, b
How much of Merck KGaA's operational expenditure (OPEX) is eligible under the EU Taxonomy?
In 2024, Merck KGaA reported that EUR 35.00 million of its operational expenditure (OPEX) was eligible under the EU Taxonomy, representing 1.35% of the company's total OPEX. Of this amount, EUR 1.00 million (0.02% of total OPEX) was classified as Taxonomy-aligned. This means that 1.33% of Merck KGaA's OPEX is eligible but not aligned, indicating that these expenditures either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Merck KGaA's eligible OPEX is aligned with the EU Taxonomy?
In 2024, Merck KGaA reported that EUR 1.00 million of its OPEX was aligned under the EU Taxonomy, representing 0.02% of its total operational expenditure.a
This low alignment reflects limited operational focus on green activities, suggesting that sustainability considerations have yet to be fully integrated into core operating processes.
Merck KGaA's Eligibility & Alignment Overview
Merck KGaA's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex
How is Merck KGaA's taxonomy-aligned OPEX distributed across the EU environmental objectives?
In 2024, Merck KGaA reported that its taxonomy-aligned operational expenditure (OPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.02%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%
How much of Merck KGaA's operational budget supports climate-related solutions?
In 2024, Merck KGaA allocated EUR 518,200 of its OPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.02% of the company's total OPEX,indicating that Merck KGaAhas only a limited share of operational expenditure aligned with climate goals, signaling early-stage or minimal integration of climate objectives into its routine activities.a
Want Full Access to Merck KGaA's EU Taxonomy Dataset?
b
b
a
b
c
a
b
c
b
a
b
c
b
c
b
c
a
b
c
b
a
b
b
c